Literature DB >> 25986061

Low-grade adenosquamous carcinoma of the breast: A diagnostic and clinical challenge.

Qing Ting Tan1, Esther Wee Lee Chuwa2, Sung Hock Chew3, Soo Kim Lim-Tan4, Swee Ho Lim5.   

Abstract

Adenosquamous carcinoma of the breast (ASBC) is a rare variant of metaplastic breast cancer with both glandular as well as squamous differentiation. Their lack of distinct imaging characteristics, sometimes subtle histological characteristics and overlapping features with other benign lesions pose a diagnostic challenge. Unlike other forms of metaplastic breast cancer, low-grade adenosquamous carcinoma (LGAC) tends to follow an indolent course with favourable prognosis. We reviewed eight cases of LGAC in our institution from June 2005 to March 2014. In six cases, LGAC was only found after excisional biopsy. In our patients, LGAC frequently co-existed with other forms of breast pathology. Two patients had incidental findings of LGAC alongside their primary malignant tumour (adenoid cystic carcinoma and invasive ductal carcinoma in one, four foci between 0.5 and 4.0 mm within a radial sclerosing lesion adjacent to a malignant phyllodes tumour in the other). A further four patients had LGAC within a complex sclerosing lesion. One patient had a focus of LGAC within a fibroadenoma. One had a focus of LGAC within a benign phyllodes tumour. None of the patients had evidence of nodal involvement. A high degree of suspicion is recommended as such lesions tend to be incidental histological findings within benign tumours or within complex sclerosing lesions. Although the risk of nodal and distant metastasis is low, the potential for local recurrence necessitates aggressive local excision with margin clearance. The role of axillary dissection has yet to be defined and routine sentinel node biopsy and axillary clearance may not be necessary in view of rarity of nodal metastasis in literature. Benefit from adjuvant radiotherapy or chemotherapy is not clearly defined. All eight patients in our study have shown no evidence of recurrence after definitive surgery but longer periods of surveillance is required.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosquamous; Breast; Cancer; Carcinoma; Metaplastic

Mesh:

Year:  2015        PMID: 25986061     DOI: 10.1016/j.ijsu.2015.05.010

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

1.  Adenosquamous Carcinoma of the Breast: Case Report and Literature Review.

Authors:  Shista Priyadarshini; Neha Singh; Haadi Ali; Vineela Kasireddy
Journal:  Cureus       Date:  2022-06-14

Review 2.  Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management.

Authors:  Emad A Rakha; Sunil Badve; Vincenzo Eusebi; Jorge S Reis-Filho; Stephen B Fox; David J Dabbs; Thomas Decker; Zsolt Hodi; Shu Ichihara; Andrew H S Lee; José Palacios; Andrea L Richardson; Anne Vincent-Salomon; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

3.  Expression of hormone receptors in low-grade adenosquamous carcinoma of the breast: A case report.

Authors:  Hai-Bo Wu; An-Li Zhang; Wei Wang; Heng Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

4.  Bilateral synchronous low-grade adenosquamous carcinoma of the breast: A Case report with review of the current literature.

Authors:  J L Senger; P Meiers; R Kanthan
Journal:  Int J Surg Case Rep       Date:  2015-07-13

5.  Adenosquamous carcinoma of the tongue: A case report and an overview of histogenetic concepts.

Authors:  Manoj Prabhakar; B Sabarinath; B Sivapathasundharam; V Vasanthakumar
Journal:  J Oral Maxillofac Pathol       Date:  2020-02-28

6.  Low-Grade Adenosquamous Carcinoma of the Axilla of Breast Origin in a Male: A Case Report and Literature Review.

Authors:  Xingqiang Yan; Fanshuang Zhu; Qiupeng Wang; Lijie Chen; Yixing Zhou; Zenggui Wu; Linhang Mei; Zhaosheng Ma; Binbin Cui; Feilin Cao
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.